Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Lagerqvist

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Journal of Health Economics|March 6, 2023
Providers, peers and patients. How do physicians' practice environments affect patient outcomes?Daniel Avdic, Maryna Ivets, Bo Lagerqvist, et al.
Journal of the American Heart Association|November 1, 2021
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without DiabetesViveca Ritsinger, Emil Hagström, Bo Lagerqvist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 4, 2010
Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Martin Kreutzer, Anders Magnuson, Bo Lagerqvist, et al.
American Heart Journal|December 13, 2006
Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery diseaseNina Johnston, Tomas Jernberg, Bo Lagerqvist, et al.
Journal of the American Heart Association|June 17, 2015
ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudyOle Fröbert, Fredrik Calais, Stefan K James, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2019
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Per Grimfjärd, Bo Lagerqvist, David Erlinge, et al.
The American Journal of Medicine|March 15, 2011
The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary interventionMarkus Lingman, Per Albertsson, Johan Herlitz, et al.
Clinical Chemistry|May 27, 2003
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudyPer Venge, Nina Johnston, Bo Lagerqvist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Torsten Schwalm, Jörg Carlsson, Axel Meissner, et al.
The American Journal of Cardiology|February 24, 2006
Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkersNina Johnston, Tomas Jernberg, Bo Lagerqvist, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Journal of Health Economics|March 6, 2023
Providers, peers and patients. How do physicians' practice environments affect patient outcomes?Daniel Avdic, Maryna Ivets, Bo Lagerqvist, et al.
Journal of the American Heart Association|November 1, 2021
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without DiabetesViveca Ritsinger, Emil Hagström, Bo Lagerqvist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 4, 2010
Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Martin Kreutzer, Anders Magnuson, Bo Lagerqvist, et al.
American Heart Journal|December 13, 2006
Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery diseaseNina Johnston, Tomas Jernberg, Bo Lagerqvist, et al.
Journal of the American Heart Association|June 17, 2015
ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudyOle Fröbert, Fredrik Calais, Stefan K James, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2019
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Per Grimfjärd, Bo Lagerqvist, David Erlinge, et al.
The American Journal of Medicine|March 15, 2011
The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary interventionMarkus Lingman, Per Albertsson, Johan Herlitz, et al.
Clinical Chemistry|May 27, 2003
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudyPer Venge, Nina Johnston, Bo Lagerqvist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Torsten Schwalm, Jörg Carlsson, Axel Meissner, et al.
The American Journal of Cardiology|February 24, 2006
Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkersNina Johnston, Tomas Jernberg, Bo Lagerqvist, et al.
Pageof 16